Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REMASTer: REcurrent Brain Metastases After SRS Trial

NCT05124912 is registered in ClinicalTrials.gov with Monteris Medical as lead sponsor.

NCT NCT05124912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05124912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REMASTer: REcurrent Brain Metastases After SRS Trial
Lead sponsor
Monteris Medical
Phase
Not applicable
Overall status
Recruiting
Start date
May 10, 2022
Completion date
October 31, 2028
Enrollment
261 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, radiation necrosis, recurrent metastases, recurrent tumor